Philip Morris Boosts Dividend for 18th Consecutive Year Amid Market Shifts

In a notable display of financial resilience, Philip Morris International has announced a substantial increase to its shareholder dividend. This move stands in stark contrast to the margin pressures currently affecting numerous consumer goods giants. The tobacco and reduced-risk products company raised its quarterly payout by a robust 8.9%, bringing it to $1.47 per share. This marks the eighteenth consecutive year of dividend growth for the firm since its 2008 spin-off.

Strategic Pivot and Market Pressures

The company’s strategic emphasis on smoke-free alternatives continues to yield significant results. Deliveries for the ZYN nicotine pouch brand surged by 43% during the second quarter of 2025. This growth in the future-oriented segment, which now accounts for 41% of net revenue, occurred alongside a 1.5% decline in traditional cigarette volume. However, this primary growth driver is facing intensified competition, particularly within the highly lucrative United States market, presenting a considerable challenge.

Should investors sell immediately? Or is it worth buying Philip Morris?

Analyst Caution Contrasts with Management Optimism

Despite the confident signal sent by the dividend hike, market analysts maintain a measured outlook. Financial institution UBS recently adjusted its assessment, lowering the price target for Philip Morris shares from $177 to $166 while reaffirming a “Neutral” rating. The revision was attributed to downward adjustments in the sales forecast for ZYN products for the 2025/26 period, highlighting underlying concerns about the core growth business.

In a contrasting stance, the company’s leadership has expressed optimism, having raised the full-year profit guidance. Although the share price currently trades approximately 13% below its peak in June, it has still demonstrated strong performance since the start of the year. The central question for investors remains whether Philip Morris can sustainably meet the high expectations for its ZYN product line or if this period of consistent dividend growth is approaching an inflection point.